About
Technology
Issues
FAQ
Links
Official Page
Anti-GITR agonist TRX518 in combination with gemcitabine in advanced solid cancers: Preliminary safety and efficacy from a multi-center phase Ib trial
site/software ©
exaly
; All materials licenced under
CC by-SA
.